Central venous catheters (CVC) have revolutionized the care of patients requiring long-term
venous access. With increasing use of CVCs, the incidence of catheter-related thrombosis …

The anticoagulation field is experiencing a renaissance that began with regulatory approval
of the direct thrombin inhibitor dabigatran, a direct oral anticoagulant (DOAC), in 2010. The …

Objective To determine hospital-associated venous thromboembolism (HA-VTE) risk factors
in critically ill neonates. Methods We conducted a case-control study in the neonatal …

Introduction: The incidence of venous thromboembolism in children has increased
significantly over the past 20 years. Over the same period of time, there was an increase in …

Pediatric acute lymphoblastic leukemia (ALL) has achieved close to 90% cure rates through
extensive collaborative and integrative molecular research, clinical studies, and advances in …

The etiology of pediatric venous thromboembolic disease (VTE) is multifactorial, and in most
children, 1 or more clinical risk factors are present. In addition, inherited thrombophilic …

Objective To identify risk factors associated with venous and arterial thrombosis in sick
neonates admitted to the neonatal intensive care unit. Study design A case-control study …

The incidence of venous thromboembolism (VTE) in children is rising. Hence, there is an
increasing off-label use of low-molecular-weight heparin (LMWH). There is little data about …

1920s from studies on the “hemorrhagic” effect of spoiled sweet clover consumption by
cattle1 and have evolved ever since to the cornerstone of oral anticoagulation therapy. The …

Introduction Cancer is a known risk factor for venous thromboembolism (VTE) in adults, but
population-based data in children are scarce. Materials and methods We conducted a …